Member Spotlight

Leslie Citrome, MD, MPH Transdermal Patches in Psychiatry: Interview with Dr. Leslie Citrome August 2019

 

Manish Kumar Jha, MD Anti-Inflammatory Treatments for Major Depressive Disorder: What’s on the Horizon?

 

Rajiv Radhakrishnan, MD; Mohini Ranganathan, MD; and Deepak Cyril D’Souza MD  Medical Marijuana: What Physicians Need to Know

 

Justin Faden, DO Treatment Resistant Schizophrenia, A Brief Overview of Treatment Options

 

Teddy J. Akiki, MD, and Chadi G. Abdallah, MD Are There Effective Psychopharmacologic Treatments for PTSD?

 

S. Nassir Ghaemi, MD, MPH; Ira D. Glick, MD,*; and James M. Ellison, MD, MPH A Commentary on Existential Psychopharmacologic Clinical Practice: Advocating a Humanistic Approach to the “Med Check”

 

Michael E. Thase, MD A Note from the ASCP President

 

Trisha Suppes, MD, PhD, Depression With Mixed Features in Major Depressive Disorder: A New Diagnosis or There All Along?

 

Ahmed N. Hassan, MD, FRCPC, MPH, Patients With Alcohol Use Disorder Co-Occurring With Depression and Anxiety Symptoms: Diagnostic and Treatment Initiation Recommendations January 2018

 

Amanda Tinkelman, MD, Emily A. Hill, MD, Kristina M. Deligiannidis, MD, Management of New Onset Psychosis in the Postpartum Period November 2017

 

Joseph F. Goldberg, MD, Do You Order Pharmacogenetic Testing? Why? August 2017

 

Jose M. Rubio, MD, & Christoph U. Correll, MD, Duration and Relevance of Untreated Psychiatric Disorders, 2: Nonpsychotic Psychiatric Disorders and Substance Use Disorders. May 2017

 

Jose M. Rubio, MD, & Christoph U. Correll, MD, Duration and Relevance of Untreated Psychiatric Disorders, 1: Psychotic Disorders. April 2017

 

Arif Khan, MD, High Risk of Death Participating in Drug Trials with a Psychiatric Illness. August 2013